Progressive autologous graft-versus-host disease induced by cyclosporin A

Bone Marrow Transplantation

Volumn 18, Issue 3, 1996, Pages 659-662

  Barredo, J C ^a,b   Yusuf, U ^a   Hahn, A ^a   Abboud, M R ^a   Laver, J ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Bone marrow transplantation; Cyclosporin A; Graft versus host disease

Indexed keywords

CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT;

ACUTE LYMPHOBLASTIC LEUKEMIA; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CASE REPORT; GRAFT VERSUS HOST REACTION; HUMAN; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RELAPSE;

BONE MARROW TRANSPLANTATION; CHILD, PRESCHOOL; CYCLOSPORINE; GRAFT VS HOST DISEASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; MALE; TRANSPLANTATION, AUTOLOGOUS;

EID: 0029839340     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Billingham RE. The biology of graft-versus-host reactions. Harvey Lectures 1966-1967; 62: 21-78.
2. Rappeport JM, Mihm M, Reinherz EL et al. Acute graft-versus-host disease in recipients of bone marrow transplants from identical twin donors. Lancet 1979; 2: 717-720.
3. Sullivan KM, Weiden PL, Storb R et al. Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia. Blood 1989; 73: 1720-1728.
4. Weisdorf DJ, Nesbit ME, Ramsay MKC et al. Allogeneic bone marrow transplantation for acute lymphoblastic leukemia in remission: prolonged survival associated with acute graft-versus-host disease. J Clin Oncol 1987; 5: 1348-1355.
5. Glazier A, Tutschka PH, Farmer ER, Santos GW. Graft-versus-host disease in cyclosporine A treated rats after syngeneic and autologous bone marrow reconstitution. J Exp Med 1983; 158: 1-8.
6. Beschorner WE, Shinn CA, Fischer AC et al. Cyclosporine-induced pseudo-graft-versus-host disease in the early post-cyclosporine period. Transplantation 1988; 46: 112S-117S.
7. Fischer AC, Beschorner WE, Hess AD. Age related factors in the induction of syngeneic GVHD. Transplant Proc 1989; 21: 3033-3035.
8. Jones RJ, Vogelsang GB, Hess AD et al. Induction of graft-versus-host disease after autologous bone marrow transplantation. Lancet 1989; 1: 754-756.
9. Dale BM, Atkinson K, Kotasek D et al. Cyclosporine-induced graft vs host disease in two patients receiving syngeneic bone marrow transplants. Transplant Proc 1989; 21: 3816-3817.
10. Carella AM, Gaozza E, Congiu A et al. Cyclosporine-induced graft-versus-host disease after autologous bone marrow transplantation in hematological malignancies. Ann Hematol 1991; 62: 156-159.
11. Santos GW. Autologous graft-versus-host disease. Leukemia 1992; 6: (Suppl. 4): 110-111.
12. Yeager AM, Vogelsang GB, Jones RJ et al. Induction of cutaneous graft-versus-host disease by administration of cyclosporine to patients undergoing autologous bone marrow transplantation for acute myeloid leukemia. Blood 1992; 79: 3031-3035.
13. Hess AD, Horwitz L, Beschorner WE et al. Development of graft-versus-host disease-like syndrome in cyclosporine-treated syngeneic bone marrow transplantation. I: Development of cytotoxic T lymphocytes with apparent polyclonal anti-Ia specificity, including autoreactivity. J Exp Med 1985; 161: 718-730.
14. Foon KA, Todd RF. Immunologic classification of leukemia and lymphoma. Blood 1986; 68: 1-31.
15. Beschorner WE, Tutschka PJ, Santos GW. Characterization of T lymphocyte subsets in target tissues with acute and chronic graft-versus-host disease (GVHD). Fed Proc 1982; 41: 620A.
16. Parkman R. Clonal analysis of murine graft-versus-host disease: 1. Phenotypic and functional analysis of T lymphocyte clones. J Immunol 1986; 136: 3543-3548.
17. Hood AF, Vogelsang GB, Black LP et al. Acute graft-versus-host disease, development following autologous and syngeneic bone marrow transplantation. Arch Dermatol 1987; 123: 745-750.
18. Einsele H, Ehninger G, Schneider EM et al. High frequency of graft-versus-host-like syndromes following syngeneic bone marrow transplantation. Transplantation 1988; 45: 579-585.
19. Storb R, Deeg HJ, Whitehead J et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft-versus-host disease after marrow transplantation for leukemia. New Engl J Med 1986; 314: 729-735.